MaxCyte (MXCT) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
MaxCyte, Inc. has announced a significant change in its shareholding structure as BlackRock, Inc. reported an increase in its voting rights to 8.75%, up from 9.37%. This adjustment underscores BlackRock’s strategic maneuvers in the financial market, marking its influence in the biopharmaceutical sector.
For further insights into MXCT stock, check out TipRanks’ Stock Analysis page.
